Ding Qiu M, Zhou Wu Q, Mao Wei L, Zhang Jin F
Clin Lab. 2020 Mar 1;66(3). doi: 10.7754/Clin.Lab.2019.190635.
Hepatitis B virus (HBV)-associated decompensated cirrhosis (HBV-DeCi) has a high mortality rate if liver transplantation is not performed. The study aimed to evaluate the association between the mean platelet volume to platelet count ratio (MPR) and outcomes of HBV-DeCi patients.
This was a retrospective study of 109 patients newly diagnosed with HBV-DeCi. Univariate and multivariate regression models were used to determine risk factors for 90-day mortality.
The MPR was observed to be higher in nonsurvivors than in survivors. Multivariate analysis suggested that the model for end-stage liver disease score and MPR were independent predictors in HBV-DeCi patients.
This study demonstrated that the MPR can serve as a potential predictor of 3-month mortality in HBV-DeCi patients.
如果不进行肝移植,乙型肝炎病毒(HBV)相关失代偿性肝硬化(HBV-DeCi)的死亡率很高。本研究旨在评估平均血小板体积与血小板计数比值(MPR)与HBV-DeCi患者预后之间的关联。
这是一项对109例新诊断为HBV-DeCi患者的回顾性研究。采用单因素和多因素回归模型确定90天死亡率的危险因素。
观察到非存活者的MPR高于存活者。多因素分析表明,终末期肝病评分模型和MPR是HBV-DeCi患者的独立预测因素。
本研究表明,MPR可作为HBV-DeCi患者3个月死亡率的潜在预测指标。